"Fosaprepitant dimeglumine (Emend, Merck) is now approved in the United States as a single-use injection to prevent delayed nausea and vomiting in adults receiving initial and repeat courses of moderately emetogenic chemotherapy (MEC); it"...
BiCNU (carmustine) should not be given to individuals who have demonstrated a previous hypersensitivity to it.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 12/13/2016
Additional BiCNU Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.